Results 261 to 270 of about 2,491,987 (318)

Editorial: Drug development for respiratory infectious diseases and related complications in other systems. [PDF]

Front Med (Lausanne)
Yu X, Wang Y, Oliva A, Xue M.
europepmc   +1 more source

Drugs in developing countries

BMJ, 1986
openaire   +3 more sources

Has FDA's Drug Development Tools Qualification Program Improved Drug Development? [PDF]

Ther Innov Regul Sci
Yang F, Bousnina I, Madej A, Kalamegham R.   +3 more
europepmc   +1 more source

Supply and Demand in the Mathematics of Rare Disease Drug Development: Why Choosing the Right Model Is Crucial. [PDF]

Clin Transl Sci
Summar ML, Woodcock J.
europepmc   +1 more source

In Silico Clinical Trials in Drug Development: A Systematic Review. [PDF]

Ther Innov Regul Sci
Chen B, Schneider LC, Röver C, Comets E, Elze MC, Hooker A, IntHout J, Jannot AS, Julkowska D, Mimouni Y, Savelieva M, Stallard N, Ursino M, Vandemeulebroecke M, Weber S, Posch M, Zohar S, Friede T.   +17 more
europepmc   +1 more source

Organs-on-Chips in Drug Development: Engineering Foundations, Artificial Intelligence, and Clinical Translation. [PDF]

Biosensors (Basel)
Roy N, Cucullo L.
europepmc   +1 more source

Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer's Disease. [PDF]

Molecules
Niziński P, Szalast K, Makuch-Kocka A, Paruch-Nosek K, Ciechanowska M, Plech T.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug-Glycosidation and Drug Development

Mini-Reviews in Medicinal Chemistry, 2013
Ideally a drug should be administered in a form that it exerts its pharmacological action at the target site using the lowest concentration possible and without undesirable effects. Drug targeting is the approach which is followed for the purpose. Among different approaches preparation of synthetic glycosides of target drug and administering them ...
Vijay K, Kapoor, Amanpreet, Kaur
openaire   +2 more sources